Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
6,728
0.11% 63
2026
Q1
$1.46M Sell
6,728
-185
-3% -$41K 0.11% 64
2025
Q4
$1.58M Buy
6,913
+6
+0.1% +$1.37K 0.12% 59
2025
Q3
$1.6M Buy
6,907
+897
+15% +$183K 0.12% 59
2025
Q2
$1.12M Buy
6,010
+527
+10% +$97.9K 0.09% 67
2025
Q1
$1.15M Buy
5,483
+370
+7% +$71.9K 0.11% 61
2024
Q4
$909K Hold
5,113
0.08% 66
2024
Q3
$1.01M Sell
5,113
-100
-2% -$18.7K 0.09% 66
2024
Q2
$894K Buy
5,213
+100
+2% +$16.6K 0.09% 68
2024
Q1
$931K Buy
5,113
+10
+0.2% +$1.72K 0.1% 70
2023
Q4
$791K Sell
5,103
-17
-0.3% -$2.48K 0.09% 77
2023
Q3
$763K Sell
5,120
-81
-2% -$11.9K 0.09% 75
2023
Q2
$701K Buy
5,201
+81
+2% +$11.9K 0.08% 83
2023
Q1
$816K Sell
5,120
-1,389
-21% -$212K 0.1% 81
2022
Q4
$1.05M Buy
6,509
+310
+5% +$47.5K 0.13% 74
2022
Q3
$832K Buy
6,199
+100
+2% +$14.3K 0.12% 81
2022
Q2
$934K Sell
6,099
-20
-0.3% -$3.06K 0.13% 77
2022
Q1
$992K Sell
6,119
-86
-1% -$12.5K 0.11% 72
2021
Q4
$840K Buy
6,205
+1,198
+24% +$142K 0.09% 73
2021
Q3
$1M Buy
5,007
+51
+1% +$5.83K 0.12% 56
2021
Q2
$1M Hold
4,956
0.13% 55
2021
Q1
$1M Hold
4,956
0.13% 55
2020
Q4
$1M Hold
4,956
0.15% 52
2020
Q3
$434K Hold
4,956
0.07% 75
2020
Q2
$487K Buy
+4,956
New +$436K 0.09% 72

Other funds holding ABBV

RVW Wealth's ABBV Position: Q2 2026 in Review

RVW Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 6,728 shares worth $1.69M. The position accounts for 0.11% of the portfolio, ranked #63.

RVW Wealth first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RVW Wealth held 6,728 shares of AbbVie worth $1.69M as of Q2 2026.
  • RVW Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.11% of RVW Wealth's portfolio in Q2 2026, its #63 holding.
  • RVW Wealth first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RVW Wealth's 13F filing for Q2 2026, filed 8 Jul 2026.